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Running title: Photodynamic inactivation of C. albicans by HMME 21 
 22 
ABSTRACT Aim: To evaluate the capacity of hematoporphyrin monomethyl ether 23 
(HMME) in the presence of light to cause photodynamic inactivation (PDI) of C. 24 
albicans. Materials & methods: HMME photoactivity was evaluated against 25 
azole-susceptible and resistant C. albicans. The mechanisms by which PDI of C. 26 
albicans occurred were also investigated. Results: HMME-mediated PACT caused a 27 
dose-dependent inactivation of azole-susceptible and resistant C. albicans. Incubation 28 
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with 10 μM HMME and irradiation with 72 J cm-2 light decreased the viability of C. 1 
albicans by 7 log10, induced damage of genomic DNA, led to loss of cellular proteins, 2 
and damaged the cell wall, membrane, and intracellular targets. Conclusion: C. 3 
albicans can be effectively inactivated by HMME in the presence of light, and 4 
HMME-mediated PACT shows potential as an antifungal treatment. 5 
 6 
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Candida albicans, which is present in the normal microbiota of healthy individuals, is 10 
an opportunistic commensal pathogen that lives in the oral cavity, gastrointestinal 11 
tract, and vagina [1]. It causes a wide range of human diseases ranging from 12 
superﬁcial mucosal infections to life-threatening invasive candidiasis in 13 
immunocompromised patients [2-4]. Most treatments available for systemic and 14 
invasive candidiasis are based on antifungal drugs including azoles, polyenes, 15 
pyrimidine, and echinocandins. However, these drugs can be toxic to the host [5] and 16 
can damage and interrupt cellular functions [6]. Moreover, the extensive and 17 
repetitive use of antifungal drugs has resulted in the development of drug-resistant C. 18 
albicans strains, and the occurrence of infections refractory to standard antifungal 19 
therapy has increased [7, 8]. Thus, development of alternative methods to manage 20 
drug resistance is imperative. 21 
One promising therapeutic approach is photodynamic antimicrobial 22 
chemotherapy (PACT), which uses a photosensitizer (PS) that is excited from a 23 
ground state to a triplet state upon illumination with light of an appropriate 24 
wavelength. The triplet state PS reacts with oxygen in and around the cells, thereby 25 
forming singlet oxygen (1O2) or other reactive oxygen species (ROS) [9] that rapidly 26 
react with nonspecific microbial targets and irreversibly destroy microbial cells 27 
through chemical and phototoxic reactions [10]. PACT has several advantages over 28 
traditional therapies, including high target specificity through direct application of PS 29 
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and light irradiation to the target sites [11], low risk of chemical and thermal side 1 
effects [12], biocompatibility with human cells [13], and low potential for 2 
development of drug resistance due to the non-speciﬁc action of liberated 1O2 or other 3 
ROS [5]. 4 
Hematoporphyrin monomethyl ether (HMME) is a second-generation, 5 
porphyrin-related PS developed in China [14]. It consists of a mixture of the two 6 
positional isomers 3-(1-methyloxyethyl)-8-(1-hydroxyethyl) deuteroporphyrin IX and 7 
8-(1-methyloxyethyl)-3-(1-hydroxyethyl) deuteroporphyrin IX (Figure 1) [15]. 8 
Compared to ﬁrst-generation PS, e.g., Photofrin and hematoporphyrin derivative 9 
(HpD), HMME has a known structure, higher photoactivity, stronger photodynamic 10 
efﬁciency, lower toxicity, and a faster clearance rate. Moreover, HMME is less costly 11 
than other photoactive drugs [16-20]. In previous studies it has been shown that in the 12 
presence of light HMME is effective at killing several types of cancer cells [19-22] 13 
and some Gram-positive and Gram-negative bacteria [23, 24]. However there are no 14 
reported studies on the capacity of this porphyrin to cause photodynamic inactivation 15 
(PDI) of C. albicans. Therefore, we conducted this study to assess the potential of 16 
HMME to mediate PDI of drug-resistant and drug-sensitive strains of C. albicans and 17 
evaluated the effects of treatment on cell macromolecular structure, DNA and protein. 18 
Material & methods 19 
 C. albicans strains & culture conditions 20 
A standard C. albicans strain (ATCC 10231) and an azole-resistant clinical isolate of 21 
C. albicans were obtained from the First Affiliated Hospital of Xi’an Jiaotong 22 
University, Xi’an, China. The strains were grown aerobically on Sabouraud dextrose 23 
agar (SDA, Nisuvi Sehuu Biotech, China) at 37°C for 48 h. The colonies were 24 
transferred into 15 ml Sabouraud dextrose broth (SDB, Nisuvi Sehuu Biotech, China) 25 
and incubated overnight at 37°C. Cell pellets were collected by centrifugation (4000 26 
rpm for 10 min, Thermo Fisher D-37520, Germany) and washed three times with 27 
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sterile phosphate-buffered saline (PBS, pH 7.0). The pellets were resuspended to a 1 
cell density of 1 × 107 colony forming units (CFU)/ml before the experiments. 2 
 PS & light source 3 
Drug-grade HMME was purchased from Shanghai Xianhui Pharmaceutical Co., 4 
China. A 1 mM stock solution was freshly prepared by dissolving the PS in PBS and 5 
stored in the dark. The stock solution was ﬁltered through a 0.22-μm filter disk and 6 
diluted to the desired concentration with PBS before use. All illuminations were 7 
performed with white light from a 150 W xenon lamp (Ceaulight CEL-HXF300, 8 
China) with a wavelength range 400–780 nm selected by an optical ﬁlter (Ceaulight 9 
CEL-UVIRCUT PD-145, China). To avoid sample heating, the light was passed 10 
through a 1-cm water ﬁlter. The fluence rate at the level of the samples was 40 mW 11 
cm-2, as measured by a power meter (Ceaulight CEL-NP2000, China). 12 
 PDI on C. albicans 13 
Samples of the yeast suspension (2 ml, 1 × 107 CFU/ml) were centrifuged at 4000 rpm 14 
for 10 min. The pellets were resuspended in 2 ml of PBS containing HMME at 15 
various concentrations (0.01–10 μM) and incubated at 37°C in the dark for 30 min in 16 
a shaking incubator (100 rpm). The samples were transferred to sterile 35-mm 17 
polystyrene culture dishes and irradiated for 30 min (total energy dose of 72 J cm-2). 18 
After irradiation, yeast suspensions were centrifuged at 4000 rpm for 10 min. The 19 
pellets were resuspended, serially diluted 10-fold with PBS and 20 μl of each dilution 20 
was spread in triplicate on SDA. Colonies were counted after 24 h incubation at 37°C. 21 
The fraction of surviving yeast was calculated as the CFU/ml after exposure to light 22 
divided by the CFU/ml before light exposure. All experiments were performed three 23 
times. 24 
 Genomic DNA purification & electrophoresis 25 
To determine if PDI of C. albicans occurred through DNA damage, genomic DNA 26 
was extracted and analyzed by agarose gel electrophoresis. After PDI treatment (10 27 
μM HMME and 72 J cm-2 white light), genomic DNA was immediately extracted 28 
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using a Genomic DNA Purification Kit (Promega, USA). DNA samples were mixed 1 
with 6 × loading-buffer (0.25% w/v bromophenol blue, 40% w/v sucrose, 1.15% 2 
acetic acid, 40 mM Tris, 1 mM EDTA) and analyzed by electrophoresis in a 1% 3 
agarose gel in Tris/Borate/EDTA buffer (TBE; 90 mM Tris-HCl, 90 mM boric acid, 4 
and 2 mM EDTA, pH 8) at 2.9 V cm-1 for 1.5 h. Ethidium bromide (1 μg/ml) was 5 
incorporated into the agarose gel, and a Lambda DNA/HindIII digest marker with 6 
125–23,130-bp DNA fragments (Promega, USA) was used as a molecular weight 7 
marker. 8 
 Protein extraction & SDS-PAGE 9 
Whole-cell protein extraction was performed according to a previously described 10 
method [25]. After PDI treatment, yeast suspensions were centrifuged at 4000 rpm for 11 
10 min. The pellets were washed twice with PBS and resuspended in 200 μl sample 12 
buffer containing 0.06 M Tris-HCl, pH 6.8, 2% (w/v) SDS, 5% (v/v) 13 
β-mercaptoethanol, 10% (v/v) glycerol, 1 mM phenylmethylsulfonylﬂuoride, and 0.5% 14 
(w/v) bromophenol blue. The samples were boiled for 20 min, and 10 μl of each 15 
sample was loaded onto a 10% (w/v) polyacrylamide gel and subjected to 16 
electrophoresis at 80 V for 10 h. The reservoir buffer consisted of 0.25 M Tris-HCl, 17 
1.92 M glycine, and 1% (w/v) SDS. A Biostep Prestained Protein Marker (Tanon, 18 
China) with a range of proteins 10–170 kDa was used as molecular weight marker. 19 
The gel was stained with 0.05% (w/v) Coomassie Brilliant Blue R 250 for 4 h and 20 
destained in 10% (v/v) acetic acid and 20% (v/v) methanol. 21 
 Fluorescence labeling 22 
For intracellular localization of HMME, the yeast cells were incubated with HMME 23 
and a DNA-speciﬁc ﬂuorescent dye, Hoechst 33342 (Sigma-Aldrich, China). After 24 
PDI treatment, yeast suspensions were centrifuged at 4000 rpm for 10 min. The 25 
pellets were resuspended in 2 ml Hoechst 33342 (1 μg/ml) in PBS and incubated in 26 
the dark at room temperature for 10 min in a shaking incubator (100 rpm). Labeled 27 
cells were washed three times with PBS, spotted on glass slides and immobilized by 28 
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the coverslips. Cell imaging was conducted on a confocal microscope (Olympus 1 
FluoView FV1000, Japan). Images were captured with CFI VC 60× oil immersed 2 
optics. Confocal images of HMME and Hoechst 33342 ﬂuorescence were collected 3 
using solid-state diode lasers, with 543 and 351 nm excitation wavelengths, 4 
respectively, and with appropriate emission ﬁlters. 5 
 Transmission electron microscopy (TEM) 6 
TEM samples were prepared according to a previously described method [26]. After 7 
PDI treatment, yeast cells were centrifuged at 4000 rpm for 10 min and fixed in 2.5% 8 
glutaraldehyde at 4°C for 2 h. The pellets were washed with PBS three times and 9 
fixed in 1% osmium tetroxide at 4°C for 2 h. Thereafter, the pellets were dehydrated 10 
with ethanol gradients and embedded in Epon 812 epoxy resin (SPI-Chem, USA) at 11 
60°C for 24 h. Thin-section samples of 50–70 nm were prepared using a LKB-V 12 
ultratome (LKB, Sweden). The samples were stained with uranyl acetate and lead 13 
citrate for 15 min, respectively. Finally, the samples were viewed and digitally 14 
photographed using a TEM (Hitachi H-7650, Japan). 15 
 Scanning electron microscopy (SEM) 16 
After PDI treatment, yeast suspensions were transferred into the wells of a sterile 17 
24-well polystyrene microplate (Corning, USA) that contained sterile glass coverslips 18 
and incubated at 37°C for 1 h. The coverslips were gently washed with PBS three 19 
times and fixed in 2.5% glutaraldehyde at 4°C for 2 h. Then, the coverslips were 20 
washed with PBS three times and fixed in 1% osmium tetroxide at 4°C for 2 h. After 21 
dehydration with ethanol gradients, the samples were freeze-dried, sputter-coated with 22 
gold, and observed using an SEM (Hitachi TM-1000, Japan). 23 
Results 24 
 PDI 25 
Before and after irradiation, sample temperatures were 35.1 and 32.3°C, respectively, 26 
as measured by a thermocouple (IKA EST-D5, Germany) at room temperature, 27 
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indicating that the light had no heating effect on these samples. HMME did not have 1 
any dark toxicity towards the two C. albicans strains at the concentrations and times 2 
tested (Figure 2). Furthermore, direct exposure of these strains to light in the absence 3 
of HMME produced no cytotoxic effect (data not shown). In contrast, treatment with 4 
0.01 μM HMME and irradiation with 72 J cm-2 white light achieved 0.90 and 0.78 5 
log10 reductions in the number of viable C. albicans ATCC 10231 and the 6 
azole-resistant clinical isolate of C. albicans, respectively. The number of viable yeast 7 
was further reduced with increasing concentrations of HMME; treatment with 1 μM 8 
HMME in the presence of 72 J cm-2 white light yielded 4.26 and 3.88 log10 reductions 9 
in the number of viable C. albicans ATCC 10231 and the azole-resistant clinical 10 
isolate of C. albicans, respectively. Furthermore no viable cells were detected after 11 
irradiation in the presence of 10 μM HMME, representing a 7 log10 reduction (Figure 12 
2). 13 
 Photodynamic effect on genomic DNA and whole-cell protein 14 
As shown in Figure 3, genomic DNA isolated from the C. albicans strains treated 15 
with 10 μM HMME alone or irradiated with light alone migrated the same distance as 16 
DNA from untreated cells, suggesting that neither HMME nor white light caused 17 
macroscale DNA damage. However, after irradiation of HMME-treated cells, a loss of 18 
intensity of intensity of the genomic DNA band was seen on gels, with some smearing 19 
indicating that HMME-mediated PDI induced DNA damage in C. albicans (Figure 20 
3). 21 
The photodynamic effect on whole-cell protein was examined by SDS-PAGE. 22 
We observed no obvious changes in the protein patterns of yeast cells treated with 23 
HMME alone or irradiated with light alone compared to that of untreated cells 24 
(Figure 4). On the other hand, after treatment with HMME and irradiation with white 25 
light, there was a loss of protein bands separated on the gel for both C. albicans ATCC 26 
10231 and the azole-resistant clinical isolate of C. albicans. 27 
 Fluorescence confocal microscopy 28 
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Figure 5 shows the confocal ﬂuorescence microscopy images of C. albicans cells. 1 
Before irradiation, spots of HMME ﬂuorescence were visible in the periphery of most 2 
cells, while strong fluorescence in the entire cell was seen in individual cells (DIC 3 
and HMME, L-). The nucleus was clearly differentiated as punctate blue 4 
ﬂuorescence (Hoechst 33342 and Merge, L-). However after 72 J cm-2 irradiation in 5 
the presence of HMME all cells showed strong ﬂuorescence in the entire cell (DIC 6 
and HMME, L+). HMME ﬂuorescence was observed in the nucleus, indicating that 7 
HMME entered the nucleus after PDI treatment. Moreover, Hoechst staining was not 8 
confined to the nucleus, and all cells showed blue ﬂuorescence in the entire cell 9 
(Hoechst 33342 and Merge, L+). 10 
 Photodynamic effect on cellular structure 11 
The yeast cells were analyzed by TEM to determine if the photodynamic effect 12 
mediated by HMME caused any morphological changes in cellular structure. 13 
Representative results are shown in Figure 6. Typical C. albicans morphology with a 14 
characteristically thick cell wall, intact plasma membrane, and irregularly shaped 15 
nucleus was observed for untreated cells (P-L-) and for cells treated with HMME 16 
alone (P+L-) or light alone (P-L+). The ribosomes were visible as dark particles 17 
dispersed in the cytoplasm. Treatment with 10 μM HMME and irradiation with 72 J 18 
cm-2 of white light induced visible damage to the cell wall, membrane, cytoplasm, and 19 
nucleus (P+L+). The cell envelopes showed shape changes characterized by cell wall 20 
swelling and membrane rupture, and nuclei were not visible. 21 
 SEM 22 
Yeast cells were analyzed with SEM to determine whether the photodynamic effect 23 
mediated by HMME affected cell surface characteristics (Figure 7). A normal round 24 
shape was observed for untreated cells (P-L-) and for cells treated with HMME alone 25 
(P+L-) or light alone (P-L+). In contrast, hollow cracks were observed on the surface 26 
of C. albicans cells treated with 10 μM HMME and irradiated by 72 J cm-2 white light 27 
(P+L+). 28 
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Discussion 1 
Previous studies have shown that C. albicans is sensitive to lethal PDI mediated by a 2 
wide variety of PSs (Table 1) such as methylene blue (MB) [27], toluidine blue O 3 
(TBO) [28], 5-aminolaevulinic acid (5-ALA) [29], rose bengal [30], porphyrins 4 
[31-33], and phthalocyanine [34]. MB and TBO are well-studied cationic 5 
phenothiazinium dyes and effective PSs that have been demonstrated to mediate PDI 6 
of several microorganisms [10]. Although C. albicans can be photodynamically 7 
inactivated in the presence of either MB or TBO, it is much less susceptible than 8 
bacteria, possibly due to differences in the ratio of cell size to volume. C. albicans 9 
cells are approximately 25–50 times larger than bacterial cells and therefore require 10 
more damage to induce cell death [35]. In the present study, 1 μM HMME in the 11 
presence of 72 J cm-2 white light yielded 4.26 and 3.88 log10 reductions in the viability 12 
of C. albicans ATCC 10231 and the azole-resistant clinical isolate of C. albicans, 13 
respectively. Comparison of this result with that of previously published data for MB 14 
and TBO (Table 1) suggests that HMME is more efficacious at mediating PDI of C. 15 
albicans. 16 
Cationic PSs are more efficient than their neutral or anionic counterparts in the 17 
PDI of bacteria [36], with many anionic or neutral PSs becoming more effective 18 
against Gram-negative bacteria when they are co-administrated with an outer 19 
membrane-disrupting agent such as CaCl2, EDTA, or polymyxin B nonapeptide [37, 20 
38]. Although HMME is an anionic porphyrin derivative our findings demonstrate 21 
that it is as efficacious at mediating PDI of C. albicans as the cationic porphyrin and 22 
phthalocyanine derivatives listed in Table 1. To the best of our knowledge, there is no 23 
direct evidence that anionic PSs are less efficient than their cationic counterparts in 24 
the PDI of Candida species.  25 
There are only a few reported studies that have examined PDI efficacy of 26 
drug-resistant C. albicans. Using a porphyrin-based PS, Dovigo et al. found that 27 
azole-resistant Candida strains were more resistant to PDI than azole-sensitive strains 28 
[39]. On the other hand, Mang et al. found that ﬂuconazole- and amphotericin 29 
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B-resistant Candida strains isolated from AIDS patients were equally susceptible to 1 
Photofrin-mediated PDI compared to non-resistant strains [40]. Our data demonstrates 2 
that the susceptibility of C. albicans strains to HMME-mediated PDI is not affected or 3 
impaired in any way by their resistance to azole antifungal agents. This finding 4 
suggests that HMME would be a good PS to use in PACT of drug-resistant strains. 5 
PDI of microorganisms has been proposed to occur through inactivation of a 6 
number of biomolecules. For example, DNA damage would interfere with 7 
chromosome segregation, DNA replication, and transcription. Quiroga et al. 8 
investigated the mechanism of the PDI of C. albicans mediated by cationic porphyrin 9 
derivatives [26] and found no signiﬁcant cleavage of genomic DNA after treatment 10 
despite efficient yeast cell photoinactivation. The authors hypothesized that either 11 
damage to genomic DNA was not involved in the PDI process or that any damage to 12 
the DNA resulting from a few lesions was not sufﬁcient to induce DNA strand breaks 13 
that could be detected by gel electrophoresis. On the other hand, Lam et al. 14 
demonstrated that DNA fragmentation occurred with silicon phthalocyanine (Pc 15 
4)-mediated PDI of C. albicans [41]. PDI mediated by 0.6 μM Pc 4 produced a DNA 16 
fragmentation pattern on electrophoresis gels matching that produced by hydrogen 17 
peroxide treatment, with a complete loss of banding and extensive migration of small 18 
DNA fragments. In this study, we observed a reduction in the amount of genomic 19 
DNA that could be purified from C. albicans and a reduction in Hoechst staining of 20 
intracellular nucleic acid. In addition the genomic DNA that was detected by gel 21 
electrophoresis ran as a faint smear indicating that HMME-mediated PDI induced 22 
DNA damage in C. albicans consistent with the study by Lam et al, although it is 23 
likely that the reduction in DNA content was also a result of cellular leakage. We also 24 
investigated the HMME-mediated PDI effect on C. albicans cellular proteins by 25 
SDS-PAGE. After treatment with 10 μM HMME and irradiation with 72 J cm-2 white 26 
light, there was an evident loss of proteins in both C. albicans ATCC 10231 and the 27 
azole-resistant clinical isolate of C. albicans. Similar findings were also found in the 28 
PDI of methicillin-resistant Staphylococcus aureus mediated by cationic T4 porphyrin 29 
[42]. Dosselli et al. hypothesized that the loss of proteins was likely due to the 30 
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formation of cross-linked complexes of protein resulting in high-molecular weight 1 
aggregates that could be found on the top of the SDS-PAGE gels. However, in the 2 
present investigation the high-molecular weight aggregates was not detected in 3 
Figure 4. Photodynamic inactivation and degradation of isolated bacterial proteins 4 
has been demonstrated previously [43] and it is possible that HMME-mediated PDI of 5 
C. albicans caused degradation of intracellular proteins, however it is also highly 6 
likely that intracellular protein was lost by leakage of cellular contents. 7 
The confocal ﬂuorescence microscopy images indicated that most of the HMME 8 
did not enter cells during incubation in the dark but bound to the cell envelope, 9 
resulting in a weak peripheral ﬂuorescence pattern, although some individual cells did 10 
display intracellular HMME. After irradiation by a light dose of 72 J cm-2, all cells 11 
showed HMME ﬂuorescence in the entire cell, indicating that the cell membrane was 12 
sufficiently damaged to allow HMME to enter cells. Furthermore upon irradiation in 13 
the presence of HMME, Hoechst ﬂuorescence was not confined to the nucleus, 14 
indicating nuclear rupture and biopolymer release. Our findings are very similar to 15 
those obtained for the PDI of C. albicans mediated by HpD [44, 45] and porphyrin 16 
TriP[4] [33]. HpD uptake by C. albicans is insignificant [44], and its photocytotoxic 17 
activity mainly occurs through unbound molecules in the aqueous medium. After 18 
irradiation, these molecules cause an initial alteration of the cytoplasmic membrane 19 
that allows HpD to penetrate into the cell, translocate to the inner membranes, and 20 
induce damage of intracellular targets [44]. Lambrechts et al. concluded that the 21 
plasma membrane became permeable during PDI, but cellular inactivation was 22 
attributed to damage of intracellular targets following PS uptake [33]. However, in the 23 
PDI of C. albicans mediated by Pc 4, Lam et al. found that the majority of Pc 4 24 
ﬂuorescence was detected in the cytoplasm and not in the cell wall, plasma membrane, 25 
nor the nucleus [41], similar to its distribution in mammalian cells [46]. The 26 
differences between the findings of Lam et al. and the results we present here suggest 27 
that the targets of porphyrin and phthalocyanine photosensitizers in the PDI of C. 28 
albicans are distinct. 29 
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The TEM images of C. albicans provided detailed information about the damage 1 
induced by HMME-mediated PDI to the plasma membrane and cytoplasmic 2 
organelles. HMME-mediated PDI damage to the cell wall, cell membrane, cytoplasm, 3 
and nucleus was visible by TEM. The ruptured nucleus was consistent with the 4 
nuclear damage inferred from fluorescence confocal microscopy. A previous study 5 
reported by Monfrecola et al. indicated that 5-ALA in the presence of white light 6 
induced membrane ruptures and cell wall swelling of C. albicans [29], which was also 7 
observed in the present study. Using freeze-fracture electron microscopy, Lambrechts 8 
et al. concluded that the yeast cytoplasmic membrane is the target of TriP[4]-mediated 9 
photoinactivation [33], which was consistent with our TEM results. On the other hand, 10 
the SEM images provided direct evidence that damage to the cell envelope was 11 
induced during PDI treatment, which could be observed on surface of C. albicans 12 
cells. 13 
Conclusion & future perspective 14 
The signiﬁcant burden of dermatophytoses and the worldwide increase in fungal 15 
strains resistant to the current antifungals increases the urgency for the development 16 
of new therapeutic strategies, such as PACT. The present study assessed the efficacy 17 
of HMME to mediate PDI of C. albicans strains in vitro. HMME effectively 18 
photo-inactivated the yeast cells in a concentration-dependent manner but exhibited 19 
no significant dark toxicity. The susceptibility of C. albicans strains to 20 
HMME-mediated PDI was not affected or impaired in any way by the yeast being 21 
resistant to azole antifungal agents, suggesting that HMME would be a good PS to use 22 
in PACT of drug-resistant C. albicans strains. Our data also indicate that 23 
HMME-mediated PDI of C. albicans occurs through damage to multiple cell targets, 24 
including genomic DNA, the cell wall, the cell membrane, the cytoplasm, the nucleus 25 
and possibly intracellular protein. These findings provide insights into 26 
HMME-mediated PDI of C. albicans. HMME-mediated PACT shows promise for 27 
development as an antifungal treatment. Of course our studies were conducted with 28 
planktonic yeast and there may be differences in the effectiveness against biofilm 29 
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grown cells. The incorporation of HMME into liposomes, micelles, or nanoparticles is 1 
a promising approach to enhance targeted delivery. The development of these vehicles 2 
is particularly important for the potential expansion of PACT for the treatment of deep 3 
fungal infections using ﬁber optic lasers, applied endoscopically, or interstitially. 4 
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EXECUTIVE SUMMARY 13 
Photodynamic inactivation of C. albicans 14 
 Without irradiation, HMME exhibited no significant dark toxicity.  15 
 After irradiated with 72 J cm-2 white light, HMME caused dose-dependent 16 
inactivation of C. albicans.  17 
 10 μM HMME in the presence of 72 J cm-2 white light yielded 7 log10 reductions 18 
in the number of viable C. albicans ATCC 10231 and the azole-resistant clinical 19 
isolate of C. albicans. 20 
Photodynamic effect on genomic DNA and whole-cell protein 21 
 After treated with 10 μM HMME and irradiated with 72 J cm-2 white light, 22 
damage of genomic DNA and loss of cellular proteins were observed in both C. 23 
albicans ATCC 10231 and the azole-resistant clinical isolate of C. albicans. 24 
Fluorescence confocal microscopy 25 
14 
 
 The majority of HMME bound to the cell envelope of C. albicans under dark 1 
conditions, with little entering the cell.  2 
 After irradiated with 72 J cm-2 white light in the presence of HMME, the cell 3 
membrane became permeable, and cell inactivation was attributed to membrane 4 
damage followed by damage to intracellular targets. 5 
TEM & SEM investigation 6 
 TEM images indicated that 10 μM HMME in the presence of 72 J cm-2 white 7 
light caused damage to the cell wall, cell membrane, cytoplasm, and nucleus. 8 
 SEM images provided direct evidence that damage to the cell envelope was 9 
induced during PDI treatment. 10 
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 1 
Figure 2. Survival of C. albicans ATCC 10231 (blue) and the azole-resistant 2 
clinical isolate of C. albicans (red) treated with different concentrations of 3 
HMME. Filled circles (●) represent the number of yeast surviving after incubation 4 
without illumination (dark toxicity), while filled squares (■) represent the number of 5 
yeast surviving after 30-min irradiation (40 mW cm-2). All the experiments were 6 
repeated for three times. 7 
  8 
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Figure 3. Agarose gel electrophoresis of genomic DNA samples extracted from 2 
albicans (ATCC 10231, 3 
albicans (lanes 5–8). Lane M:4 
2 and 6: incubated with 10 μM5 
irradiated with 400–780 nm white light6 
incubated with 10 μM HMME and 7 
(72 J cm-2). 8 
 9 
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 1 
Figure 4. Image of an SDS-PAGE gel with protein samples from C. albicans 2 
ATCC 10231 (lanes 1–4) and the azole-resistant clinical isolate of C. albicans 3 
(lanes 5–8). Lane M: DNA weight maker. Lanes 1 and 5: no treatment. Lanes 2 and 4 
6: incubated with 10 μM HMME at 37°C for 30 min in the dark. Lanes 3 and 7: 5 
irradiated with 400–780 nm white light for 30 min (72 J cm-2). Lanes 4 and 8: 6 
incubated with 10 μM HMME and irradiated with 400–780 nm white light for 30 min 7 
(72 J cm-2). 8 
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 1 
Figure 5. Confocal ﬂuorescence microscopy images of C. albicans. (L-): C. 2 
albicans cells were incubated with 10 μM HMME at 37°C for 30 min in the dark and 3 
labeled with 1 μg/ml Hoechst 33342 in the dark at room temperature for 10 min. (L+): 4 
C. albicans cells were incubated with 10 μM HMME at 37°C for 30 min in the dark 5 
and irradiated with 400–780 nm white light for 30 min (72 J cm-2). Then the cells 6 
were labeled with 1 μg/ml Hoechst 33342 in the dark at room temperature for 10 min. 7 
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 1 
Figure 6. Transmission electron microscopy images of C. albicans. (P-L-): no 2 
treatment. (P+L-): incubated with 10 μM HMME at 37°C for 30 min in the dark. 3 
(P-L+): irradiated with 400–780 nm white light for 30 min (72 J cm-2). (P+L+): 4 
incubated with 10 μM HMME and irradiated with 400–780 nm white light for 30 min 5 
(72 J cm-2). 6 
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 1 
Figure 7. Scanning electron microscopy images of C. albicans. (P-L-): no 2 
treatment. (P+L-): incubated with 10 μM HMME at 37°C for 30 min in the dark. 3 
(P-L+): irradiated with 400–780 nm white light for 30 min (72 J cm-2). (P+L+): 4 
incubated with 10 μM HMME and irradiated with 400–780 nm white light for 30 min 5 
(72 J cm-2). 6 
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Table 1. PDI of C. albicans mediated by various photosensitizers. 1 
Photosensitizer Concentration Light dose Reduction of viable cells Reference 
Methylene blue 312 μM 39.5 J cm-2 2.7 log10 [27] 
Toluidine blue O 25 μM 180 J cm-2 5.2 log10 [28] 
5-ALA 2.98 M 40 J cm-2 ~1.0 log10 [29] 
Rose bengal 200 μM 42.63 J cm-2 4-6 log10 [30] 
Porphyrin XF-73 1 μM 12.1 J cm-2 over 5.0 log10 [31] 
Porphyrin  
Tetra-Py+-Me 
10 μM 64.8 J cm-2 6.5 log10 [32] 
Porphyrin TriP[4] 25 μM 12.6 J cm-2 5.6 log10 [33] 
Phthalocyanine ZnPPc4+ 1 μM 54 J cm-2 4.0 log10 [34] 
HMME 1 μM 72 J cm-2 ~4.0 log10 This study 
HMME 10 μM 72 J cm-2 7 log10 This study 
Porphyrin XF-73: dicat ionic 5, 15-bis-[4-(3-trimethylammoniopropyloxy)-phenyl]-porphyrin; Porphyrin Tetra-Py+-Me: 5, 10, 15, 20- 2 
tetrakis (1-methylpyrid-inium-4-yl) porphyrin tetra-iodide; Porphyrin TriP[4]: 5-phenyl-10, 15, 20-Tris(N-methyl-4-pyridyl)porphyrin 3 
chloride; Phthalocyanine ZnPPc4+: zinc(II) 2, 9, 16, 23-tetrakis[4-(N-methylpyridy-loxy)]phthalocyanine. 4 
